ShareMyTrial
Sign In
Arthritis
Published Research

SAM-e (S-Adenosylmethionine) for Hip and Knee Osteoarthritis

150 participants

Symptoms Studied

Joint pain, stiffness, and reduced mobility in the hip and/or knee due to osteoarthritis, affecting walking and daily activities.

Research Hypothesis

SAM-e is involved in cartilage formation and has anti-inflammatory properties. It may reduce pain and improve function while supporting joint health.

Intervention Tested

S-Adenosylmethionine (SAM-e)

400mg SAM-e three times daily (1200mg total), taken orally

Duration: 30 days

Study Results

Before Treatment

Adults with hip and/or knee osteoarthritis experiencing pain and functional limitations.

After Treatment

SAM-e showed slightly better activity than ibuprofen in managing painful symptoms of osteoarthritis. Only 5 patients on SAM-e reported minor side effects vs 16 on ibuprofen.

Timeline to Improvement

Improvements observed over 30 days of treatment

Side Effects

Very well-tolerated. Significantly fewer side effects than ibuprofen (5 vs 16 patients). No dropouts or abnormal lab changes.

Source

Conclusion

SAM-e is as effective as ibuprofen for osteoarthritis pain relief with significantly fewer side effects, making it a valuable option for those who cannot tolerate NSAIDs.

Comments (0)

Did this work for you?

Share your experience

Sign in to vote

Try It Yourself

Create your own trial based on this study and share your results.

Replicate This Trial

Similar Trials

More trials for Arthritis coming soon.

Browse all Arthritis trials